MARATTO

article · Webbia

Keetia nodulosa sp. nov. (Rubiaceae - Vanguerieae) of West-Central Africa: bacterial leaf nodulation discovered in a fourth genus and tribe of Rubiaceae

202412 citationsOpen accessUniversité de Yaoundé I

Abstract

Keetia nodulosa Cheek, a cloud forest climber nearly endemic to Cameroon, with a single record from Nigeria, is described and illustrated. It is remarkable as the first known species to be recorded with bacterial leaf nodules (BLN) in the genus Keetia, and also, in the tribe Vanguerieae. Other genera in Rubiaceae with BLN are Psychotria (Psychotrieae-Rubioideae), Sericanthe (Coffeeae) and Pavetta (Pavetteae), both Ixoroideae/Dialypetalanthoideae. The BLN in Keetia (Vanguerieae) are illustrated for the first time here. The characteristics and significance of bacterial leaf nodulation in Keetia nodulosa are discussed in the context of rapidly growing knowledge on the subject in flowering plants. Keetia nodulosa is provisionally assessed using the 2012 IUCN standard as Endangered (EN B2ab(iii)). The importance of its conservation, and options for achieving this are discussed in the context of recent extinctions of other plant species in Cameroon. This discovery of a new cloud forest species is discussed in relation to other cloud forest plant species described in the last twenty years which are also distributed over the highlands of the western half of Cameroon.

Research topics

  • Plant and Fungal Species Descriptions
  • Plant Diversity and Evolution
  • Plant Pathogens and Fungal Diseases

Sustainable Development Goals

Read the original research

This page summarises published work. The authoritative version sits with the publisher.

DOI: 10.36253/jopt-15946

Is something wrong with this record? Report it or request removal.

Discussion

Discuss this research

Have you built on this work, tried to replicate it, or seen it applied in practice? Share what you know. Verified researchers and MARATTO™ domain experts can open a discussion, and any member can reply. Contributions are reviewed before they appear.

No discussion yet. Open the first thread.